Vascular

Rishi Gupta, MD
Department of Neurology, Section of Stroke and Neurological Critical Care, The Cleveland Clinic Foundation

Derk W. Krieger, MD, PhD
Department of Neurology, Section of Stroke and Neurological Critical Care, The Cleveland Clinic Foundation

Address: Derk W. Krieger, MD, PhD, Department of Neurology, Section of Stroke and Neurological Critical Care, S91, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Krieger has indicated that he is on the speakers’ bureau of BMS and is a consultant for Boehringer Ingleheim.

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Rishi Gupta, MD
Department of Neurology, Section of Stroke and Neurological Critical Care, The Cleveland Clinic Foundation

Derk W. Krieger, MD, PhD
Department of Neurology, Section of Stroke and Neurological Critical Care, The Cleveland Clinic Foundation

Address: Derk W. Krieger, MD, PhD, Department of Neurology, Section of Stroke and Neurological Critical Care, S91, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Krieger has indicated that he is on the speakers’ bureau of BMS and is a consultant for Boehringer Ingleheim.

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

Rishi Gupta, MD
Department of Neurology, Section of Stroke and Neurological Critical Care, The Cleveland Clinic Foundation

Derk W. Krieger, MD, PhD
Department of Neurology, Section of Stroke and Neurological Critical Care, The Cleveland Clinic Foundation

Address: Derk W. Krieger, MD, PhD, Department of Neurology, Section of Stroke and Neurological Critical Care, S91, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Krieger has indicated that he is on the speakers’ bureau of BMS and is a consultant for Boehringer Ingleheim.

This paper discusses therapies that are experimental or are not approved by the US Food and Drug Administration for the use under discussion.

H. Leon Daneschvar, MD
Fairview Hospital, Cleveland Clinic Health System

Hamed Daw, MD
Community Oncology Group, Cleveland Clinic Westlake (OH)

Address: Hamed Daw, MD, Cleveland Clinic Westlake, WL20, 30033 Clemens Road, Westlake, OH 44145; e-mail [email protected]

H. Leon Daneschvar, MD
Fairview Hospital, Cleveland Clinic Health System

Hamed Daw, MD
Community Oncology Group, Cleveland Clinic Westlake (OH)

Address: Hamed Daw, MD, Cleveland Clinic Westlake, WL20, 30033 Clemens Road, Westlake, OH 44145; e-mail [email protected]

H. Leon Daneschvar, MD
Fairview Hospital, Cleveland Clinic Health System

Hamed Daw, MD
Community Oncology Group, Cleveland Clinic Westlake (OH)

Address: Hamed Daw, MD, Cleveland Clinic Westlake, WL20, 30033 Clemens Road, Westlake, OH 44145; e-mail [email protected]

Stephen P. Emery, MD
Section of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, The Cleveland Clinic Foundation

Address: Stephen P. Emery, MD, Department of Obstetrics and Gynecology, M66, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Stephen P. Emery, MD
Section of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, The Cleveland Clinic Foundation

Address: Stephen P. Emery, MD, Department of Obstetrics and Gynecology, M66, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

Stephen P. Emery, MD
Section of Maternal-Fetal Medicine, Department of Obstetrics and Gynecology, The Cleveland Clinic Foundation

Address: Stephen P. Emery, MD, Department of Obstetrics and Gynecology, M66, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic. They are approved by the author but are not peer-reviewed.

John R. Bartholomew, MD
Department of Cardiovascular Medicine, Section of Vascular Medicine, The Cleveland Clinic Foundation

Terry King, MD
Department of Vascular Surgery, The Cleveland Clinic Foundation

Avisesh Sahgal, MD
Department of Vascular Surgery, The Cleveland Clinic Foundation

Allison T. Vidimos, MD
Department of Dermatology, The Cleveland Clinic Foundation

Address: John R. Bartholomew, MD, Department of Cardiovascular Medicine, Section of Vascular Medicine, S60, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

John R. Bartholomew, MD
Department of Cardiovascular Medicine, Section of Vascular Medicine, The Cleveland Clinic Foundation

Terry King, MD
Department of Vascular Surgery, The Cleveland Clinic Foundation

Avisesh Sahgal, MD
Department of Vascular Surgery, The Cleveland Clinic Foundation

Allison T. Vidimos, MD
Department of Dermatology, The Cleveland Clinic Foundation

Address: John R. Bartholomew, MD, Department of Cardiovascular Medicine, Section of Vascular Medicine, S60, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

John R. Bartholomew, MD
Department of Cardiovascular Medicine, Section of Vascular Medicine, The Cleveland Clinic Foundation

Terry King, MD
Department of Vascular Surgery, The Cleveland Clinic Foundation

Avisesh Sahgal, MD
Department of Vascular Surgery, The Cleveland Clinic Foundation

Allison T. Vidimos, MD
Department of Dermatology, The Cleveland Clinic Foundation

Address: John R. Bartholomew, MD, Department of Cardiovascular Medicine, Section of Vascular Medicine, S60, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Joseph P. Broderick, MD
Professor and Chair, Department of Neurology, University of Cincinnati

Address: Joseph P. Broderick, MD, Professor and Chair of Neurology, University of Cincinnati Medical Center, 231 Albert B. Sabin Way, Cincinnati, OH 45267-0525

The author has indicated that he has received grant or research support from and serves as a consultant for the Novo Nordisk corporation.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.

Joseph P. Broderick, MD
Professor and Chair, Department of Neurology, University of Cincinnati

Address: Joseph P. Broderick, MD, Professor and Chair of Neurology, University of Cincinnati Medical Center, 231 Albert B. Sabin Way, Cincinnati, OH 45267-0525

The author has indicated that he has received grant or research support from and serves as a consultant for the Novo Nordisk corporation.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.

Joseph P. Broderick, MD
Professor and Chair, Department of Neurology, University of Cincinnati

Address: Joseph P. Broderick, MD, Professor and Chair of Neurology, University of Cincinnati Medical Center, 231 Albert B. Sabin Way, Cincinnati, OH 45267-0525

The author has indicated that he has received grant or research support from and serves as a consultant for the Novo Nordisk corporation.

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.

Mark A. Crowther, MD
Division of Hematology, McMaster University, Hamilton, Ontario

Address: Mark A. Crowther, MD, Division of Hematology, McMaster University, St. Joseph's Hospital, 50 Charlton Avenue East, Hamilton, Ontario L8N 4A6, Canada

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.

Mark A. Crowther, MD
Division of Hematology, McMaster University, Hamilton, Ontario

Address: Mark A. Crowther, MD, Division of Hematology, McMaster University, St. Joseph's Hospital, 50 Charlton Avenue East, Hamilton, Ontario L8N 4A6, Canada

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.

Mark A. Crowther, MD
Division of Hematology, McMaster University, Hamilton, Ontario

Address: Mark A. Crowther, MD, Division of Hematology, McMaster University, St. Joseph's Hospital, 50 Charlton Avenue East, Hamilton, Ontario L8N 4A6, Canada

Medical Grand Rounds articles are based on edited transcripts from Division of Medicine Grand Rounds presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.

Amir K. Jaffer, MD
Medical Director, the IMPACT Center and The Anticoagulation Clinic, Section of Hospital Medicine, Department of General Internal Medicine, The Cleveland Clinic Foundation

Address: Amir K. Jaffer, MD, Department of General Internal Medicine, A72, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

The author has indicated that he has received grant or research suport from the Astra Zeneca corporation, serves as a consultant for the Sanofi-Aventis corporation, and is on the speaker’s bureau of the Sanofi-Aventis corporation.

This paper discusses therapies that are experimental or that are not approved by the US Food and Drug Administration for the use under discussion.

Medical Grand Rounds articles are based on edited transcripts from presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.

Amir K. Jaffer, MD
Medical Director, the IMPACT Center and The Anticoagulation Clinic, Section of Hospital Medicine, Department of General Internal Medicine, The Cleveland Clinic Foundation

Address: Amir K. Jaffer, MD, Department of General Internal Medicine, A72, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

The author has indicated that he has received grant or research suport from the Astra Zeneca corporation, serves as a consultant for the Sanofi-Aventis corporation, and is on the speaker’s bureau of the Sanofi-Aventis corporation.

This paper discusses therapies that are experimental or that are not approved by the US Food and Drug Administration for the use under discussion.

Medical Grand Rounds articles are based on edited transcripts from presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.

Amir K. Jaffer, MD
Medical Director, the IMPACT Center and The Anticoagulation Clinic, Section of Hospital Medicine, Department of General Internal Medicine, The Cleveland Clinic Foundation

Address: Amir K. Jaffer, MD, Department of General Internal Medicine, A72, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

The author has indicated that he has received grant or research suport from the Astra Zeneca corporation, serves as a consultant for the Sanofi-Aventis corporation, and is on the speaker’s bureau of the Sanofi-Aventis corporation.

This paper discusses therapies that are experimental or that are not approved by the US Food and Drug Administration for the use under discussion.

Medical Grand Rounds articles are based on edited transcripts from presentations at The Cleveland Clinic Foundation. They are approved by the author but are not peer-reviewed.